Results

Total Results: over 10,000 records

Showing results for "treatment".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
    January 01, 2012 - diabetes and hypertension.16 In efforts to reduce the risk of complications from these conditions, therapeutic … CKD Treatment Benefits and Harms • In RCTs of patients with CKD stages 1–3, several treatments reduced … with macroalbuminuria, ACEI or ARB treatment in combination with other therapy, and treatments other … • Patient-level meta-analyses of treatment RCTs to evaluate the effect of treatments relative to … Effectiveness of statin therapy in adults with coronary heart disease.
  2. integrationacademy.ahrq.gov/products/playbooks/opioid-use-disorder/implement-mat-for-oud/service-models
    January 01, 2019 - For example, the West Virginia University Comprehensive Opioid Addiction Treatment (COAT) model uses … include: Performing the initial assessment, Delivering patient education, Making referrals to behavioral therapy … Patients are then transferred to primary care for the maintenance phase of treatment. … Documentation & Charge Capture Process: Medication-Assisted Treatment. … Principles of Substance Use Treatment Delivering Effective, Low Barrier Treatment
  3. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0645-151012.pdf
    August 05, 2015 - Also, understanding modifiers of treatment and treatment pathways can help to optimize choices for patients … Decreased medication side effects; decreased unintended consequences/harms associated with therapies … What are modifiers of treatment and treatment pathways that can help to optimize choices for patients … , including pharmacologic, psychosocial/behavioral (e.g., cognitive behavioral therapy), and complementary … An updated synthesis of treatment options can help to inform clinical decision-making.
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
    September 13, 2011 - may be extended up to 48 weeks for patients with HCV genotype 1.5,6 The effects of antiviral therapies … may change with the introduction of the new drug class.13,14 Adherence to treatments has been shown … treatment outcomes specifically in HCV antiviral therapy or whether treatment adherence interventions … training), increasing the convenience of medication use (e.g., simplifying drug dosing, tailoring the treatments … • Treatment regimens: prescribed antiviral therapy.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-adults-prisons_executive.pdf
    August 01, 2013 - Four trials tested the efficacy of pharmacologic therapies. … Investigators compared cognitive therapy with other psychological treatment in three trials. … Evidence was insufficient that any of the other treatments assessed (other pharmacologic therapies, … cognitive therapy to be more effective than other standard psychological treatment. … Direct Insufficient Modified therapeutic community vs.
  6. effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
    January 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Mesenchymal stem cell therapy for treatment of osteoarthritis 3. … = 0.043 and p = 0.010 respectively). 54 Autologous PRP is not currently considered a drug or a therapeutic … Gout therapeutics: new drugs for an old disease. Lancet 2011 Jan 8;377(9760):165-77.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd_research-protocol.pdf
    August 10, 2010 - including alternative treatments • Any pharmaceutical treatment • Any psychosocial or behavioral … or parent training treatment or combination treatment • Not including alternative treatments … • Any pharmaceutical treatment • Not including alternative treatments Comparator/ Design … or combination treatment compared against placebo or any other of the above treatments • Not case … or combination treatment compared against placebo or any other of the above treatments • Not case
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0094_04-09-2009.pdf
    January 01, 2009 - for autism including occupational, speech, and physical therapies and drug effectiveness. … Areas of interest from the second nominator include combined treatments, effectiveness of early interventions … Understanding the combined effectiveness of medical and behavioral treatments a. … treatment plus a pharmacological treatment versus pharmacological treatment alone in reducing depressive … clear that there is a real need for synthesized research that evaluates the evidence base for various treatments
  9. digital.ahrq.gov/sites/default/files/docs/publication/r18hs018665-storch-final-report-2015.pdf
    January 01, 2015 - the needs of each client and, depending on the design, could lack important therapeutic components. … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus treatment as … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus treatment as … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus treatment as … CCBT=Computer-assisted cognitive-behavioral therapy; TAU=treatment as usual; PARS=Pediatric Anxiety
  10. Hi Les, (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rtc-design-principles_research.pdf
    January 01, 2009 - Test-treatment pathway Treatment effects. … more sensitive test, just as they are needed to assess the efficacy of new treatments. … Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast … Standard for breast conservation therapy in the management of invasive breast carcinoma. … The role of before-after studies of therapeutic impact in the evaluation of diagnostic technologies
  11. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_executive.pdf
    September 01, 2011 - as therapies for patients with TRD: electroconvulsive therapy (ECT), repetitive transcranial magnetic … Comparisons of these nonpharmacologic therapies are our main interest. … How do the efficacy, effectiveness, or harms of treatment with nonpharmacologic treatments for TRD differ … Direct comparisons of treatment strategies, holding consistent any coexisting or concomitant therapies … When ongoing treatment is uncontrolled and reflects a variety of treatments—e.g., some patients continue
  12. effectivehealthcare.ahrq.gov/products/asthma-pharmacologic-treatment/research-2017
  13. effectivehealthcare.ahrq.gov/products/asthma-nonpharmacologic-treatment/research-protocol
  14. effectivehealthcare.ahrq.gov/products/asthma-pharmacologic-treatment/research-protocol
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/instrumental-variable-methods_research.pdf
    April 01, 2010 - Example 2: The Hospital Formulary Suppose that a new thrombolytic therapy is introduced for the treatment … The new medication is thought to be more effective than existing therapies, but it is expensive and … Thus, providers who preferentially use one treatment must not also preferentially use other treatments … For example, in effectiveness studies, underuse of a therapy results in the IV up-weighting the treatment … Estimating probit models with self-selected treatments. Stat Med 2006;25:389-413. 63.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0495_05-24-2013.pdf
    January 01, 2013 - Treatment options for metastatic breast cancer include hormone therapy and chemotherapy as well as radiation … therapy and/or surgery for pain relief … bone scintigraphy, CT, MRI, x-ray, ultrasound, PET/CT and FDG- PET can be used to assess response to therapy … , the results of which may affect treatment strategies and outcomes. … A variety of techniques may be used based on treatment strategy and location of metastases.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
    September 01, 2011 - Therefore it is good that this report includes trials comparing to controls, sham therapies and pharmacological … The study compares baseline and post-treatment outcomes after electroconvulsive therapy. … Their call for action, such as more uniformity in diagnosis and in therapeutic protocols, is well thought … patient receiving long-term dynamic therapy was better off than 96% of patients receiving other treatments … Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0351_05-10-2010.pdf
    January 01, 2010 - and associated abnormalities and their impact on treatment and outcomes. … cryptorchidism (undescended testicle) Intervention(s): diagnostic methods (imaging, laparoscopy), hormone therapy … , surgical therapy, specific surgical techniques, early treatment, follow-up care, counseling of patient … of treatment, medical therapies, different surgical techniques Outcome(s): diagnostic ability … uncertainty regarding appropriate diagnostic approaches for cryptorchidism as well as appropriate therapeutic
  19. digital.ahrq.gov/sites/default/files/docs/publication/uc1hs015135-arora-final-report-2008.pdf
    January 01, 2008 - cure rates are 45%-70% with the use of injection therapy for a 6-18 month period and the intensive … The only current treatment (drug therapy with Interferon and Ribavirin) of Hepatitis C involves severe … The purpose of the study was to show that Hepatitis C treatment through ECHO is as safe as therapy given … Because therapy is discontinued at 12 weeks in non-responders, SAE and treatment completion rates were … Virological response and safety outcomes in therapy-naive patients treated for chronic hepatitis C
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypothyroidism-hyperthyroidism-screening-treatment_research-protocol.pdf
    March 11, 2010 - This uncertainty impacts the decision-making for clinicians who are considering treatments for subclinical … or other acceptable options of thyroid replacement therapy, and may include inclusion of activities … Adverse reactions are usually due to therapeutic overdosage and resulting hyperthyroidism. … OR 1-9 11. therapeutic use [sh] 12. treatment [tiab] 13. therapy [tiab] 14. … OR clinical trial[Publication Type] OR random*[Title/Abstract] OR random allocation[MeSH Terms] OR therapeutic